Please use this identifier to cite or link to this item: https://doi.org/10.1002/pbc.20684
Title: Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL)
Authors: Kwok, C.S.
Kham, S.K.
Quah, T.C. 
Yeoh, A.E. 
Ariffin, H.
Lin, H.P.
Keywords: ALL
Drug efficacy
L-asparaginase
Leukemia
Minimal residual disease
Issue Date: 2006
Source: Kwok, C.S., Kham, S.K., Quah, T.C., Yeoh, A.E., Ariffin, H., Lin, H.P. (2006). Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL). Pediatric Blood and Cancer 47 (3) : 299-304. ScholarBank@NUS Repository. https://doi.org/10.1002/pbc.20684
Source Title: Pediatric Blood and Cancer
URI: http://scholarbank.nus.edu.sg/handle/10635/25684
ISSN: 15455009
15455017
DOI: 10.1002/pbc.20684
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

14
checked on Dec 11, 2017

WEB OF SCIENCETM
Citations

12
checked on Dec 11, 2017

Page view(s)

202
checked on Dec 9, 2017

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.